Dalil Hannani Selected Research

Minor Histocompatibility Antigens

2/2010

Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dalil Hannani Research Topics

Disease

17	Neoplasms (Cancer) 07/2023 - 09/2011
4	Melanoma (Melanoma, Malignant) 03/2023 - 02/2015
4	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2019 - 02/2010
2	Infections 07/2023 - 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Disease Progression 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Dysbiosis 06/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2021
1	Cystic Fibrosis (Mucoviscidosis) 01/2021
1	Experimental Arthritis 01/2019
1	Rheumatoid Arthritis 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Breast Neoplasms (Breast Cancer) 11/2014
1	Necrosis 06/2012
1	Leukemia 02/2010

Drug/Important Bio-Agent (IBA)

6	AntigensIBA 03/2023 - 02/2010
4	VaccinesIBA 03/2023 - 01/2016
3	Immune Checkpoint InhibitorsIBA 01/2023 - 11/2021
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2014
3	AnthracyclinesIBA 11/2014 - 04/2013
3	Adenosine Triphosphate (ATP)IBA 06/2013 - 06/2012
2	Inulin FDA Link 07/2023 - 01/2023
2	PrebioticsIBA 07/2023 - 01/2023
2	Neoplasm Antigens (Tumor Antigens)IBA 03/2023 - 04/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2013
2	CytokinesIBA 03/2014 - 05/2012
1	InterleukinsIBA 07/2023
1	EpitopesIBA 03/2023
1	Cancer VaccinesIBA 01/2020
1	Melanoma-Specific AntigensIBA 01/2020
1	Ficusin (Psoralen)IBA 08/2019
1	Collagen Type II (Type II Collagen)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 02/2015
1	Indicators and Reagents (Reagents)IBA 02/2015
1	IpilimumabIBA 02/2015
1	Interferon Type IIBA 11/2014
1	Trastuzumab (Herceptin)FDA Link 03/2014
1	Proteins (Proteins, Gene)FDA Link 03/2014
1	Phosphates (Orthophosphate)IBA 03/2014
1	InterferonsIBA 03/2014
1	O-cyclopentyl-S-diethylaminoethyl methylphosphonothioateIBA 03/2014
1	HMGB1 Protein (HMG1)IBA 03/2014
1	Adenosine (Adenocard)FDA LinkGeneric 03/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2014
1	CCR2 ReceptorsIBA 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2013
1	Purinergic Receptors (Receptors, Purine)IBA 04/2013
1	InflammasomesIBA 06/2012
1	Antineoplastic Agents (Antineoplastics)IBA 06/2012
1	Minor Histocompatibility AntigensIBA 02/2010

Therapy/Procedure

7	Therapeutics 01/2023 - 03/2010
7	Drug Therapy (Chemotherapy) 11/2021 - 06/2012
4	Immunotherapy 01/2023 - 05/2012
3	Photopheresis 08/2019 - 03/2010
2	Hematopoietic Stem Cell Transplantation 12/2010 - 02/2010
1	Subcutaneous Injections 01/2019
1	Radiotherapy 03/2014
1	Photochemotherapy (Photodynamic Therapy) 12/2010